Emergent BioSolutions EBS
NYSE EBS
$6.76 +0.21 (+3.21%)
At close: Sep 22, 2026 · 4:00 PM EDT

Emergent BioSolutions (EBS) Cash & Equivalents Growth (1y) (2011 - 2026)

Analysis

Emergent BioSolutions (EBS) Cash & Equivalents Growth (1y) (2011 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash & Equiv. Growth (1y) (Qtr)
1 Johnson & Johnson 649.47 Bn 628.71 Bn 17.26 Bn 9.93%
2 AbbVie 467.46 Bn 460.93 Bn 12.70 Bn 1.58%
3 Merck 369.31 Bn 362.22 Bn 12.21 Bn -14.46%
4 Novartis Ag 269.03 Bn 261.74 Bn 11.24 Bn 14.42%
5 Pfizer 158.11 Bn 146.71 Bn 10.94 Bn -40.42%
6 Bristol Myers Squibb 127.96 Bn 116.89 Bn 9.25 Bn -30.77%
7 Sanofi 51.83 Bn 44.86 Bn 10.79 Bn -57.55%
8 BeOne Medicines 41.33 Bn 36.23 Bn 1.53 Bn 84.98%
9 Revolution Medicines 41.30 Bn 41.30 Bn - -
10 Emergent BioSolutions 335.50 Mn 194.60 Mn 137.20 Mn -47.74%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -47.74%
Mar 31, 2026 7.51%
Dec 31, 2025 106.43%
Sep 30, 2025 63.78%
Jun 30, 2025 283.50%
Mar 31, 2025 89.94%
Dec 31, 2024 -10.92%
Sep 30, 2024 70.73%
Jun 30, 2024 -21.33%
Mar 31, 2024 -81.75%
Dec 31, 2023 -82.62%
Sep 30, 2023 -63.55%
Jun 30, 2023 -75.26%
Mar 31, 2023 -1.28%
Dec 31, 2022 11.54%
Sep 30, 2022 -40.34%
Jun 30, 2022 -19.98%
Mar 31, 2022 -20.45%
Dec 31, 2021 -7.28%
Sep 30, 2021 -2.70%
API Access

Emergent BioSolutions Cash & Equivalents Growth (1y) API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cash-and-equivalents-growth-1y&ticker=EBS&period=max&api_key=YOUR_API_KEY